<DOC>
	<DOCNO>NCT02230254</DOCNO>
	<brief_summary>PE PREMIER China : A Prospective , Multicenter Trial Assess Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System Treatment Atherosclerotic Lesion ( )</brief_summary>
	<brief_title>PE PREMIER CHINA CLINICAL TRIAL</brief_title>
	<detailed_description>To evaluate clinical peri-procedural angiographic outcome Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System treatment subject atherosclerotic lesion ( ) ≤34 mm length ( visual estimate ) native coronary artery ≥2.25 mm ≤4.0 mm diameter ( visual estimate )</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Clinical Inclusion ( CI ) Criteria CI1 . Subject must least 18 75 year age CI2 . Subject ( legal guardian ) understand trial requirement treatment procedure provide write informed consent trialspecific test procedure perform CI3 . Subject eligible percutaneous coronary intervention ( PCI ) CI4 . Subject symptomatic coronary artery disease objective evidence ischemia silent ischemia CI5 . Subject acceptable candidate coronary artery bypass grafting ( CABG ) CI6 . Subject willing comply protocolrequired followup evaluation CI7 . Subject leave ventricular ejection fraction ( LVEF ) &gt; 30 % measure within 60 day prior enrollment Angiographic Inclusion ( AI ) Criteria ( visual estimate ) AI1 . Target lesion ( ) must locate native coronary artery visually estimate reference vessel diameter ( RVD ) ≥2.25 mm ≤4.0 mm AI2 . Target lesion ( ) length must ≤34 mm ( Target lesion ( ) length must ≤28 mm reference vessel diameter ( RVD ) = 2.25 mm Target lesion ( ) ) ( visual estimate ) AI3 . Target lesion ( ) must visually estimate stenosis ≥50 % &lt; 100 % thrombolysis Myocardial Infarction ( TIMI ) flow &gt; 1 one following ( stenosis ≥70 % , abnormal fractional flow reserve ( FFR ) , abnormal stress test imaging stress test , elevate biomarkers ) prior procedure AI4 . Coronary anatomy likely allow delivery study device target lesion ( ) AI5 . The first lesion treat must successfully predilated/pretreated Note : Successful predilatation/pretreatment refers dilatation balloon catheter appropriate length diameter , pretreatment with/or rotational coronary atherectomy , cutting/scoring balloon great 50 % residual stenosis dissection great National Heart , Lung , Blood Institute ( NHLBI ) type C. Clinical Exclusion ( CE ) Criteria CE1 . Subject clinical symptom and/or electrocardiogram ( ECG ) change consistent Acute MI ( include STEMI Non STEMI ) within 1 week CE2 . Subject cardiogenic shock , hemodynamic instability require inotropic mechanical circulatory support , intractable ventricular arrhythmia , ongoing intractable angina CE3 . Subject receive organ transplant wait list organ transplant CE4 . Subject receive schedule receive chemotherapy within 30 day index procedure CE5 . Planned PCI ( include stag procedure ) CABG index procedure CE6 . Subject previously treat time intravascular brachytherapy CE7 . Subject know allergy contrast ( adequately premedicated ) and/or trial stent system protocolrequired concomitant medication ( e.g. , platinum , platinumchromium alloy , stainless steel , everolimus structurally related compound , polymer individual component , Clopidogrel , aspirin ) CE8 . Subject one following ( assess prior index procedure ) : Other serious medical illness ( e.g. , cancer , congestive heart failure ) estimate life expectancy le 12 month Current problem substance abuse ( e.g. , alcohol , cocaine , heroin , etc . ) Planned procedure may cause noncompliance protocol confound data interpretation CE9 . Subject receive chronic ( ≥72 hour ) anticoagulation therapy ( i.e. , heparin , coumadin ) indication acute coronary syndrome CE10 . Subject range complete blood count ( CBC ) value determine study physician clinically significant . CE11 . Subject document suspect liver disease , include laboratory evidence hepatitis CE12 . Subject dialysis baseline serum creatinine level &gt; 2.0 mg/dL ( 177µmol/L ) CE13 . Subject history bleed diathesis coagulopathy refuse blood transfusion CE14 . Subject history cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within past 6 month CE15 . Subject active peptic ulcer active gastrointestinal ( GI ) bleed CE16 . Subject sign symptom active heart failure ( i.e. , NYHA class IV ) time index procedure CE17 . Subject participate another investigational drug device clinical trial reach primary endpoint CE18 . Subject intend participate another investigational drug device clinical trial within 12 month index procedure CE19 . Subject known intention procreate within 12 month index procedure ( woman childbearing potential sexually active must agree use reliable method contraception time screen 12 month index procedure ) CE20 . Subject woman pregnant nursing ( pregnancy test must perform within 7 day prior index procedure woman childbearing potential ) CE21.Target vessel treat type PCI ( e.g. , balloon angioplasty , stent , cut balloon , atherectomy ) within 12 month prior index procedure Angiographic Exclusion ( AE ) Criteria ( visual estimate ) AE1 . Planned treatment 3 lesion . AE2 . Planned treatment lesion 2 major epicardial vessel AE3 . Planned treatment single lesion 1 stent AE4 . Subject 2 target lesion vessel separate less 20 mm ( visual estimate ) AE5 . Target lesion ( ) locate leave main AE6 . Target lesion ( ) locate within 3 mm origin leave anterior descending ( LAD ) coronary artery leave circumflex ( LCx ) coronary artery visual estimate . AE7 . Target lesion ( ) locate within saphenous vein graft arterial graft AE8 . Target lesion ( ) access via saphenous vein graft arterial graft AE9 . Target lesion ( ) TIMI flow 0 ( total occlusion ) TIMI flow 1 prior guide wire cross AE10 . Target lesion ( ) treat index procedure involve complex bifurcation ( e.g. , bifurcation lesion require treatment 1 stent ) AE11 . Target lesion ( ) restenotic previous stent implantation study stent would overlap previous stent AE12 . Subject unprotected leave main coronary artery disease ( &gt; 50 % diameter stenosis ) AE13 . Subject treat type PCI ( i.e. , balloon angioplasty , stent , cut balloon atherectomy ) within 24 hour prior index procedure AE14 . Thrombus , possible thrombus , present target vessel ( visual estimate ) AE15 . Excessive tortuosity proximal within lesion AE16 . Excessive angulation proximal within lesion AE17 . Target lesion and/or target vessel proximal target lesion moderately severely calcified visual estimate AE18 . Involves side branch ≥2.0 mm diameter visual estimate side branch &lt; 2.0 mm diameter visual estimate require treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Coronary Artery Disease</keyword>
</DOC>